Stratification of lung adenocarcinoma patients for d-limonene intervention based on the expression signature genes

Pyrolysis of citrus wastes for the simultaneous production of adsorbents for Cu(II), H2, and d-limonene

A route based on pyrolysis and physical activation with H₂O and CO₂ was proposed to reuse citrus waste traditionally discarded. The citrus wastes were orange peel (OP), mandarine peel (MP), rangpur lime peel (RLP), and sweet lime peel (SLP). The main aim was to use the solid products of this new route as adsorbents for Cu(II) ions. Copper ions are among the most important water pollutants due to their non-degradability, toxicity, and bioaccumulation, facilitating their inclusion and long persistence in the food chain. Besides the solid products, the liquid and gaseous fractions were evaluated for possible applications. Results showed that the citrus waste composition favored the thermochemical treatment. In addition, the following yields were obtained from the pyrolysis process: approximately 30 % wt. of biochar, 40 % wt. of non-condensable gases, and 30 % wt. of bio-oil. The biochars did not present a high specific surface area. Nevertheless, activated carbons with CO₂ and H₂O presented specific surface areas of 212.4 m²/g and 399.4 m²/g, respectively, and reached Cu(II) adsorption capacities of 28.2 mg g^-1 and 27.8 mg g^-1. The adsorption kinetic study revealed that the equilibrium was attained at 60 min and the pseudo-second-order model presented a better fit to the experimental data. The main generated gases were CO₂, which could be employed as an activating agent for activated carbon production. d-limonene, used for food and medicinal purposes, was the main constituent of the bio-oil.

D-Limonene inhibits the occurrence and progression of LUAD through suppressing lipid droplet accumulation induced by PM2.5 exposure in vivo and in vitro

BACKGROUND

PM_2.5 exposure is associated with lung adenocarcinoma (LUAD), but the mechanism is unclear. The lack of understanding impedes our effort on prevention. This study examined a possible mechanism of lung cancer caused by PM_2.5 exposure, and aimed to find a potential intervention for people living in PM_2.5 polluted regions.

METHODS

Electron microscopy and oil-red staining were conducted to examine the lipid droplet accumulation. Masson's trichrome staining, colony forming, scratch assay and transwell experiment were conducted to evaluate the effect of PM_2.5 exposure and D-limonene intervention on the occurrence and progression of LUAD. Potential intervention targets were found by RNA-Seq and verified by luciferase reporter assay. MiR-195 KO mice constructed with CRISPR/Cas9 technology were used to investigate the pivotal role of D-limonene-miR-195-SREBP1/FASN axis. Cohort analysis of lung cancer patients, human LUAD tissues staining and human intervention trial were also conducted to validate the results of cell and animal experiments.

RESULTS

Our results showed that PM_2.5 exposure induced accumulation of lipid droplets in LUAD cells which accompanied by increased malignant cellular behaviors. PM_2.5 exposure led to cleaved N-SREBP1 translocation into nucleus, which activated the de novo lipogenesis pathway. Same changes were also observed in normal lung epithelial cells and normal lung tissue, and mice developed pulmonary fibrosis after long-term exposure to PM_2.5. Furthermore, in a cohort of 11,712 lung cancer patients, significant lipid metabolism disorders were observed in higher PM_2.5 polluted areas. In view of that, D-limonene was found to inhibit the changes in lipid metabolism through upregulating the expression of miR-195, which inhibited the expression of lipogenic genes (SREBF1/FASN/ACACA) specifically. And a small human intervention trial showed that serum miR-195 was upregulated after oral intake of D-limonene.

CONCLUSION

Our findings reveal a new mechanism of pulmonary fibrosis and LUAD that is related to PM_2.5 exposure-induced lipid droplet accumulation. We also demonstrate that D-limonene-miR-195-SREBP1/FASN axis is a potential preventive intervention for mediating the progression and development of LUAD induced by PM_2.5 exposure. Trial registration Chinese Clinical Trial Registry, ChiCTR2000030200. Registered 25 February 2020, http://www.chictr.org.cn/showproj.aspx?proj=48013.